Quantcast

Latest Cyberonics Inc. Stories

2014-06-04 08:30:02

Fiscal 2014 Net Sales of $282 million, an 11% Increase HOUSTON, June 4, 2014 /PRNewswire/ -- Cyberonics, Inc. (NASDAQ:CYBX) today announced results for the fourth quarter and fiscal year ended April 25, 2014. Annual highlights(1) Operating results for fiscal 2014 compared to fiscal 2013, and other achievements, include: -- Record worldwide sales of $282.0 million, an increase of 10.9%; -- Record worldwide unit sales of 13,982, an increase of 8.1%; -- Record adjusted non-GAAP...

2014-05-28 08:32:49

HOUSTON, May 28, 2014 /PRNewswire/ -- Cyberonics, Inc. (NASDAQ:CYBX), a global leader in medical devices for the treatment and management of epilepsy, today announced it will participate in the William Blair 34th Annual Growth Stock Conference on Wednesday, June 11, 2014, in Chicago. Greg Browne, Cyberonics' Senior Vice President and Chief Financial Officer, will speak at 12:40 PM Central Time. A live audio webcast of the presentation can be accessed by clicking on the Investor...

2014-05-21 08:29:56

HOUSTON, May 21, 2014 /PRNewswire/ -- Cyberonics, Inc. (NASDAQ:CYBX) today announced that the company will report financial results for the fourth quarter and fiscal year ended April 25, 2014, on Wednesday, June 4, 2014, before regular market trading hours. The company will conduct a conference call to discuss those results on the same day at 8:00 AM Central Time (9:00 AM Eastern Time). Fourth Quarter and Fiscal Year 2014 Results Webcast and Conference Call Instructions The...

2014-05-06 08:36:01

Significant Improvements Observed in Quality-of-Life Measurements and Reduced Seizure Frequency Support VNS Therapy as Foundational Treatment for Refractory Epilepsy HOUSTON, May 6, 2014 /PRNewswire/ -- Cyberonics, Inc. (NASDAQ:CYBX) today announced positive results from the PuLsE (Open Prospective Randomized Long-term Effectiveness) study conducted at 28 sites in Europe and Canada and published in the peer-reviewed journal Epilepsia. The goal of this comparative effectiveness...

2014-04-28 08:32:57

HOUSTON, April 28, 2014 /PRNewswire/ -- Cyberonics, Inc. (NASDAQ:CYBX) today announced the promotion of Rohan Hoare, Ph.D., to the newly created role of Chief Operating Officer. As COO, Rohan will be responsible for the development, manufacturing, quality and commercial activities for the Epilepsy franchise. The company also announced that O'Neill F. D'Cruz, M.D. recently joined the company as Chief Medical Officer. "We have made significant, multi-year investments in our sales...

2014-02-20 08:30:49

LONDON, Feb. 20, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report:Global Electrical and Magnetic Nerve Stimulation Market 2012-2016 TechNavio's analysts forecast the Global Electrical and Magnetic Nerve Stimulation market to grow at a CAGR of 4.99 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increase in age-related neurological disorders. The Global Electrical and Magnetic Nerve Stimulation market...

2014-02-20 08:29:34

Proprietary Technology Provides Automatic Stimulation upon Seizure Detection HOUSTON, Feb. 20, 2014 /PRNewswire/ -- Cyberonics, Inc. (NASDAQ:CYBX) announced today the CE Mark (Conformité Européenne) approval in Europe for the AspireSR generator, the novel sixth-generation VNS Therapy generator. The AspireSR generator provides the well-established benefits of VNS Therapy, coupled with a new feature - Automatic Stimulation in response to detection of a seizure. Proprietary...

2014-02-20 08:29:06

Net Product Sales of $68.2 million, 9.4% Increase HOUSTON, Feb. 20, 2014 /PRNewswire/ -- Cyberonics, Inc. (NASDAQ:CYBX) today announced results for the quarter, and year-to-date, ended January 24, 2014. Quarterly highlights Operating results for the third quarter of fiscal 2014 compared to the third quarter of fiscal 2013, and other achievements, include: -- Worldwide product net sales of $68.2 million, an increase of 9.4%; -- Worldwide unit sales of 3,409, an increase of 6.0%;...

2014-02-19 16:24:40

HOUSTON, Feb. 19, 2014 /PRNewswire/ -- Cyberonics, Inc. (NASDAQ:CYBX), a global leader in medical devices for the treatment and management of epilepsy, today announced it will participate in the following conferences. Greg Browne, Cyberonics' Chief Financial Officer, will participate in one-on-one meetings with investors during the RBC Capital Markets Global Healthcare Conference in New York on Tuesday, February 25, 2014. No formal presentation is scheduled, and the one-on-one...

2014-02-04 08:36:10

HOUSTON, Feb. 4, 2014 /PRNewswire/ -- Cyberonics, Inc. (NASDAQ:CYBX) today announced that the company will report financial results for the third quarter ended January 24, 2014, of its fiscal year ending April 25, 2014, on Thursday, February 20, 2014, before regular market trading hours. The company will conduct a conference call to discuss those results on the same day at 8:00 AM Central Time (9:00 AM Eastern Time). Fiscal Year 2014 Third Quarter Results Webcast and Conference Call...


Word of the Day
sough
  • A murmuring sound; a rushing or whistling sound, like that of the wind; a deep sigh.
  • A gentle breeze; a waft; a breath.
  • Any rumor that engages general attention.
  • A cant or whining mode of speaking, especially in preaching or praying; the chant or recitative characteristic of the old Presbyterians in Scotland.
  • To make a rushing, whistling, or sighing sound; emit a hollow murmur; murmur or sigh like the wind.
  • To breathe in or as in sleep.
  • To utter in a whining or monotonous tone.
According to the OED, from the 16th century, this word is 'almost exclusively Scots and northern dialect until adopted in general literary use in the 19th.'
Related